Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2025Cell Communication and SignalingOpen Access

Phenotype switching in highly invasive resistant to vemurafenib and cobimetinib melanoma cells

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAleksandra SimiczyjewMKMagdalena KotMMMichał Majkowski

Discussion

Loading...

Member takes

Overview

Analysis reveals enhanced cell migration and invadopodia formation in melanoma cells resistant to BRAF and MEK inhibitors, suggesting new therapeutic targets.

Key Points

  • Resistant melanoma cells demonstrate significantly increased invasion and migration compared to sensitive controls.
  • Protease activity and focal adhesion kinase are elevated in double-resistant melanoma cells, indicating aggressive behavior.
  • Focal adhesion kinase activation and invadopodia formation contribute to enhanced cell mobility and invasiveness.
  • Targeting this invasive phenotype of melanoma may improve clinical outcomes for patients given current drug limitations.

Cite This Study

Simiczyjew et al. (2025) studied this question.

synapsesocial.com/papers/68fa32a40df2e6cd2f7420d8https://doi.org/10.1186/s12964-025-02452-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review2025 · 18 citations
  2. 2Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells2025
  3. 3<scp>PTRF</scp> Confers Melanoma‐Acquired Drug Resistance Through the Upregulation of <scp>EGFR</scp>2025
  4. 4Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog2025
  5. 5Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance2025